STNN-DDI: a Substructure-aware Tensor Neural Network to predict Drug–Drug Interactions
- 7 June 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 23 (4)
Abstract
Computational prediction of multiple-type drug–drug interaction (DDI) helps reduce unexpected side effects in poly-drug treatments. Although existing computational approaches achieve inspiring results, they ignore to study which local structures of drugs cause DDIs, and their interpretability is still weak. In this paper, by supposing that the interactions between two given drugs are caused by their local chemical structures (substructures) and their DDI types are determined by the linkages between different substructure sets, we design a novel Substructure-aware Tensor Neural Network model for DDI prediction (STNN-DDI). The proposed model learns a 3-D tensor of |$\langle $| substructure, substructure, interaction type |$\rangle $| triplets, which characterizes a substructure–substructure interaction (SSI) space. According to a list of predefined substructures with specific chemical meanings, the mapping of drugs into this SSI space enables STNN-DDI to perform the multiple-type DDI prediction in both transductive and inductive scenarios in a unified form with an explicable manner. The comparison with deep learning-based state-of-the-art baselines demonstrates the superiority of STNN-DDI with the significant improvement of AUC, AUPR, Accuracy and Precision. More importantly, case studies illustrate its interpretability by both revealing an important substructure pair across drugs regarding a DDI type of interest and uncovering interaction type-specific substructure pairs in a given DDI. In summary, STNN-DDI provides an effective approach to predicting DDIs as well as explaining the interaction mechanisms among drugs. Source code is freely available at https://github.com/zsy-9/STNN-DDI.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (61872297)
- Shaanxi Provincial Key Research & Development Program, China (2020KW-063)
This publication has 25 references indexed in Scilit:
- Basic Concepts in Medicinal ChemistryDrug Development and Industrial Pharmacy, 2013
- Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting SystemClinical Pharmacology & Therapeutics, 2013
- INDI: a computational framework for inferring drug interactions and their associated recommendationsMolecular Systems Biology, 2012
- Tensor factorization using auxiliary informationData Mining and Knowledge Discovery, 2012
- Data-Driven Prediction of Drug Effects and InteractionsScience Translational Medicine, 2012
- Tensor Decompositions and ApplicationsSIAM Review, 2009
- Tiering Drug-Drug Interaction Alerts by Severity Increases Compliance RatesJournal of the American Medical Informatics Association, 2009
- When good drugs go badNature, 2007
- Keynote review: In vitro safety pharmacology profiling: an essential tool for successful drug developmentDrug Discovery Today, 2005
- Simultaneous Modeling of Pharmacokinetics and Pharmacodynamics with a Nonparametric Pharmacodynamic ModelClinical Pharmacology & Therapeutics, 1984